Mass spec-based analysis of CFS patients shows an analyte signature indicative of a stalled, underperforming metabolism, and could help diagnose the condition.
The proteomic test identifies prostate cancer patients with likely non-aggressive forms of the disease that can be treated without surgery or radiation therapy.
Under the partnership, University of Victoria researchers will upload some 2,000 multiple reaction monitoring mass spec assays to the CPTAC Assay Portal.
The resource contains data on 166,174 proteotypic peptides and enables mass spec-based quantification of 20,123 of the 20,203 annotated human proteins.
The proteomic study, which built on past findings that HER2-negative tumors generate HER2-positive cells after treatment, suggests a role for combination therapy.
In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.
Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.
DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.
A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.